Alzheimer's disease and related dementias (ADRD) are progressive neurological disorders leading to severe cognitive decline, which requires comprehensive care and management for those affected.
Antipsychotic medications are commonly used to manage behavioral symptoms in ADRD patients, but they pose significant risks including increased mortality and cardiovascular events.
A study revealed that despite a decrease in antipsychotic use among older adults with ADRD from 2010 to 2017, anticonvulsant, and antidepressant medications increased, indicating potential substitution effects.
Policies aimed at reducing antipsychotic use in nursing homes did not yield a further decrease in community settings, highlighting the need for more effective strategies.
Collection
[
|
...
]